Tasly Pharmaceutical Group Co., Ltd (SHA: 600535)
China
· Delayed Price · Currency is CNY 15.59
-0.13 (-0.83%)
Nov 13, 2024, 3:00 PM CST
Tasly Pharmaceutical Group Company Description
Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally.
It provides cardiovascular, anti-tumor, cold and fever, liver disease treatment, and other disease solutions.
Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China.
Tasly Pharmaceutical Group Co., Ltd
| Country | China |
| Founded | 1994 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 9,223 |
| CEO | Jing Su |
Contact Details
Address: No. 2, Puji East Road Tianjin, 300410 China | |
| Phone | 86 22 2673 6999 |
| Website | taslypharma.com |
Stock Details
| Ticker Symbol | 600535 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001C81 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jing Su | GM and Director |
| Jie Wei | Chief Financial Officer and Head of Accounting |
| Yu Jie | Secretary and Vice President |
| Jin Yong Cai | Deputy GM and Employee Representative of the Supervisory Board |
| Hongwei Liu | Deputy GM and Vice Chairman of the Supervisory Board |
| Shunnan Zhang | Deputy GM and Supervisor |